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There is ample evidence suggesting that hepatitis C virus (HCV)-associated autoimmunity plays a role in a
broad spectrum of autoimmune diseases, which are usually overlooked. We report on a case of nephrotic
syndrome, palpable purpura, cryoglobulinemia, hypocomplementemia, and acute renal failure complicated
by immune complex glomerulonephritis (GN). The patient is a 64-year-old man with HCV infection, who
was initially considered to present only an HCV-associated cryoglobulinemic GN. However, renal biopsy
revealed a “full house” immune complex crescentic GN, which led to our subsequent investigation. The
attending clinicians faced what is a common dilemma, where an HCV-associated autoimmune disease
inevitably switches to a lupus-like GN. Hence, we also discuss treatment.
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Hepatitis C virus (HCV) is a recognized culprit in the
etiology of many glomerular diseases, which include the
principal membranoproliferative glomerulonephritis
(MPGN) type 1 disease, the less common acute proliferative
and exudative GN, as well as mixed MPGN type 1 with
overlapping membranous features [1]. HCV infection has
also been found to be strongly associated with autoimmune
disorders and immunologic abnormalities, such as with
a n t i n u c l e a r  a n t i b o d i e s  ( A N A ) ,  c r y o g l o b u l i n ,
antineutrophil cytoplasmic antibody (ANCA), cutaneous
lesions, and hypocomplementemia [2–4]. HCV may also
act as a triggering factor in the pathogenesis of systemic
lupus erythematous, or the “lupus-like syndrome” [5].
Thus, there is considerable overlap in the clinical
features of HCV infection and lupus nephritis. We hereby
report on a case that initially represented an HCV-
associated cryoglobulinemic GN. However, in view of the
progressive renal-function deterioration, a renal biopsy
was performed. This biopsy revealed an intriguing “full
house” immune complex crescentic GN, which presented
us with a further dilemma.
CASE PRESENTATION
A 64-year-old man was admitted because of proceeding
nephrotic syndrome. He presented with anasarca, dyspnea,
decreased urine amount, persistent heavy proteinuria,
and a 7-kg gain in body weight over the past 6 months. The
patient also had palpable purpura of his legs for the last
month (Figure 1). He denied having had trauma, surgery,
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exposure to Chinese herbal medicines, or systemic
diseases, except for a 10-year history of chronic hepatitis
C and a 1-year history of nephrotic syndrome. One year
previously, hypertension did not develop, and the initial
laboratory data revealed total protein, 4.6 g/dL; albumin,
1.2 g/dL; glutamic-oxaloacetic transaminase (GOT),
84 U/L; glutamic-pyruvic transaminase (GPT), 71 U/L;
total cholesterol, 412 mg/dL; blood urea nitrogen (BUN),
28.2 mg/dL; serum creatinine, 1.3 mg/dL; ANA test, 1:40;
normal complement component C3 and C4 (139 mg/dL
and 28.1 mg/dL, respectively) levels; and negative serum
cryoglobulin. Abdominal sonography demonstrated renal
parenchymal disease, normal liver appearance and a
small amount of ascites. However, he refused to undertake
renal biopsy and was lost to follow-up due to the
emergence of severe acute respiratory syndrome.
On admission, blood pressure was 160/90 mmHg, and
a massive amount of right-sided pleural effusion and
ascites were also noticed. No lymphadenopathy was
present. The laboratory data showed that BUN was 80
mg/dL; serum creatinine, 1.6 mg/dL; albumin, 1.59 g/dL,
total protein, 3.86 g/dL; total cholesterol, 201 mg/dL;
triglyceride, 75 mg/dL, GOT, 19 U/L; GPT, 12 U/L, serum
sodium, 133 meq/L; and potassium, 4.2 meq/L. Serology
showed an ANA titer of 1:40 (speckled); depressed C3 and
C4 levels (41.4 and 10.1 mg/dL, respectively); positive
serum cryoglobulin and positive p-ANCA; negative
rheumatoid factor, antistreptolysin O titer and venereal
disease research laboratory test; anti-HCV(+); HBsAg(–).
Daily protein loss (DPL) was 3.5 g, and the creatinine
clearance was 66.5 mL/min.
T h e  t e n t a t i v e  d i a g n o s i s  w a s  H C V - r e l a t e d
cryoglobulinemia. In the course of treatment, urine amount
gradually increased and body weight decreased at a rate of
less than 1 kg reduction per day, after albumin plus
furosemide infusion. However, serum creatinine increased
to 3.24 mg/dL within 1 month. Because precipitating factors
of overdiuresis and bleeding were excluded, a renal biopsy
was performed.
To our considerable astonishment, renal pathology
showed a “full house” immune complex GN (Figure 2) with
m e m b r a n o u s  n e p h r o p a t h y  s u p e r i m p o s e d  o n
membranoproliferative transition (Figure 3), and crescentic
transformation (Figure 4).
Additional studies revealed: anti-dsDNA(–), and a low
titer of ANA (1:40). The patient only fulfilled one of the 11
American Rheumatism Association (ARA) diagnostic
criteria for systemic lupus erythematosus. One the other
hand, HCV RNA was negative, and skin pathology revealed
intact vascular wall with dense perivascular lymphocytic
infiltration in the dermis, which is inconsistent with the
characteristic of HCV-associated leukocytoclastic vasculitis.
Much evidence for HCV-associated autoimmune
diseases was at hand, including cryoglobulinemia, positive
p-ANCA and low ANA titer, in concurrence with palpable
purpura and the full house immune complex GN. Therefore,
we prescribed IV methylprednisolone 500 mg for 3 days,
fo l lowing  ora l  predniso lone  20  mg/day  and
cyclophosphamide 100 mg/day for renal function
deterioration.
Figure 1. Palpable purpura over right lower leg.
Figure 2. In immunofluorescence study, the strongest granular pattern
of staining shows where IgG (3+) collects along the glomerular basement
membrane (40=).
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Surprisingly, the ascites and right-sided pleural
effusion disappeared after 3 days of pulse steroid
therapy, and renal function remained stable. Moreover,
neither abnormal liver function nor increased viral load
developed. However, the patient died of severe infection,
1 month later.
DISCUSSION
We present an unusual case of probable membranous
nephropathy, superimposed on membranoproliferative
transition, and crescentic transformation, in concurrence
with a full house immune complex GN, in an older man
with HCV infection and who developed acute renal
failure and marked extrarenal manifestations. Careful
analysis and correlation of clinical and pathologic findings
allowed us to speculate that HCV may have been an
original culprit in the development of HCV-related
autoimmune disease, with a switch to lupus-like GN. In
this case, however, the possible development of true
lupus nephritis was difficult to dismiss offhand. The full
house immune complex GN, however, seemed to have
negated the pathognomonic features to lupus nephritis
in follow-up [6,7].
HCV-associated cryoglobulinemia, in conjunction
with hypocomplementemia and palpable purpura, led
us to conclude that MPGN should be the target lesion.
However, the association with positive ANA and ANCA,
as well as the full house staining on immunofluorescence,
also suggested a possible autoimmune disorder [8].
In such cases, cryoglobulinemia may be the source of a
false negative polymerase chain reaction result in patients
with HCV-positive liver disease [9]. Therefore, we were
initially facing a therapeutic dilemma, due to the
concurrence of HCV infection and lupus-like GN. Due to
the elevated DPL of 12 g/day, which spontaneously
subsided to 4.5 g after conservative treatment, interferon-
_ therapy did not appear to be of paramount importance.
Furthermore, it was noted that autoimmune disease may
complicate antiviral therapy for HCV infection [10], and
steroid therapy is not contraindicated in patients with
HCV-associated nephropathy [11]. Hence, it was urgent
to decrease the crescent formation via pulse steroid
therapy.
To our surprise, the right-sided pleural effusion and
ascites dramatically decreased, renal function remained
stable, and the viral load did not flare up. Despite these
responses, however, the patient died of infection 1
month later.
In conclusion, this case underlies the importance of
recognizing HCV-associated autoimmunity, which usually
is overlooked. Although immunosuppression and potential
infections are often contingent to pulse steroid plus
cyclophosphamide therapy, careful supervision may
overcome these problems.
Figure 3. Electron micrograph showing irregular thickening of
glomerular basement membrane (GBM), subepithelial (thin arrow) and
predominant subendothelial (asterisk) electron dense deposits. Mesangial
cells interposition (thick arrow) with GBM duplication was indicative of
membranoproliferative glomerulonephritis transition (4000=).
Figure 4. Light microscopy showing cellular crescent (asterisk) formation
in three of the glomeruli (periodic acid-Schiff reaction) (400=).
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